Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue

Genes and Immunity

Volumn 13, Issue 8, 2012, Pages 641-652

  Zheng, J ^a   Ibrahim, S ^b   Petersen, F ^c   Yu, X ^a,c  

^a XIAMEN UNIVERSITY   (China)

^b UNIVERSITY OF LÜBECK   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

association; autoimmune diseases; meta analysis; protein tyrosine phosphatase non receptor type 22; susceptibility gene; target tissue

Indexed keywords

CYTOSINE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; THYMINE;

ADDISON DISEASE; ALLELE; ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THROMBOCYTOPENIA; GENE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GRAVES DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MYASTHENIA GRAVIS; MYOSITIS; PRIORITY JOURNAL; PTPN 22 GENE; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VITILIGO;

ALLELES; AUTOIMMUNE DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GASTROINTESTINAL TRACT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE SYSTEM; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; SKIN;

EID: 84870910115     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.46     Document Type: Article

References (144)

1. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008; 4: e1000024.
2. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
3. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
4. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504-507.
5. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53: 3020-3023.
6. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999; 93: 2013-2024.
7. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P et al. Autoimmuneassociated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317-1319.
8. Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol 2009; 182: 3343-3347.
9. Douroudis K, Shcherbakova A, Everaus H, Aints A. PTPN22 gene regulates natural killer cell proliferation during in vitro expansion. Tissue Antigens 2010; 76: 315-318.
10. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. PEST domainenriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004; 303: 685-689.
11. Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005; 76: 184-187.
12. Martin MC, Oliver J, Urcelay E, Orozco G, Gomez-Garcia M, Lopez-Nevot MA et al. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens 2005; 66: 314-317.
13. Wipff J, Allanore Y, Kahan A, Meyer O, Mouthon L, Guillevin L et al. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population. Ann Rheum Dis 2006; 65: 1230-1232.
14. Zhebrun D, Kudryashova Y, Babenko A, Maslyansky A, Kunitskaya N, Popcova D et al. Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. Aging (Albany NY) 2011; 3: 368-373.
15. Seldin MF, Shigeta R, Laiho K, Li H, Saila H, Savolainen A et al. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun 2005; 6: 720-722.
16. Fedetz M, Matesanz F, Caro-Maldonado A, Smirnov II, Chvorostinka VN, Moiseenko TA et al. The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. Tissue Antigens 2006; 67: 430-433.
17. Douroudis K, Prans E, Haller K, Nemvalts V, Rajasalu T, Tillmann V et al. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. Tissue Antigens 2008; 72: 425-430.
18. Majorczyk E, Jasek M, Ploski R, Wagner M, Kosior A, Pawlik A et al. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Eur J Hum Genet 2007; 15: 1043-1048.
19. Ploski R, Dziunycz P, Kostrzewa G, Roszkowski PI, Barcz E, Zabek J et al. PTPN22/LYP 1858C4T gene polymorphism and susceptibility to endometriosis in a Polish population. J Reprod Immunol 2009; 79: 196-200.
20. Skorka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxford) 2005; 62: 679-682.
21. az-Gallo LM, Espino-Paisan L, Fransen K, Gomez-Garcia M, van SS, Cardena C et al. Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2011; 17: 2287-2294.
22. Kokkonen H, Johansson M, Innala L, Jidell E, Rantapaa-Dahlqvist S. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 2007; 9: R56.
23. Lefvert AK, Zhao Y, Ramanujam R, Yu S, Pirskanen R, Hammarstrom L. PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J Neuroimmunol 2008; 197: 110-113.
24. Rodriguez-Rodriguez L, Taib WR, Topless R, Steer S, Gonzalez-Escribano MF, Balsa A et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 2011; 63: 365-372.
25. Skinningsrud B, Husebye ES, Gervin K, Lovas K, Blomhoff A, Wolff AB et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008; 16: 977-982.
26. Viken MK, Olsson M, Flam ST, Forre O, Kvien TK, Thorsby E et al. The PTPN22 promoter polymorphism-1123G4C association cannot be distinguished from the 1858C4T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 2007; 70: 190-197.
27. Betz RC, Konig K, Flaquer A, Redler S, Eigelshoven S, Kortum AK et al. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol 2008; 158: 389-391.
28. Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H et al. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther 2006; 8: R75.
29. Wagenleiter SE, Klein W, Griga T, Schmiegel W, Epplen JT, Jagiello P. A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet 2005; 32: 323-324.
30. Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M et al. No independent role of the-1123 G4C and\+2740 A4G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res Clin Pract 2007; 76: 297-303.
31. Hradsky O, Lenicek M, Dusatkova P, Bronsky J, Nevoral J, Valtrova V et al. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs. Tissue Antigens 2008; 71: 538-547.
32. Stark K, Rovensky J, Blazickova S, Grosse-Wilde H, Ferencik S, Hengstenberg C et al. Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls. Arthritis Res Ther 2009; 11: R70.
33. Nielsen C, Hansen D, Husby S, Lillevang ST. Sex-specific association of the human PTPN22 1858T-allele with type 1 diabetes. Int J Immunogenet 2007; 34: 469-473.
34. Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 2005; 6: 584-587.
35. Hinks A, Eyre S, Barton A, Thomson W, Worthington J. Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK. Ann Rheum Dis 2007; 66: 683-686.
36. Kemp EH, McDonagh AJ, Wengraf DA, Messenger AG, Gawkrodger DJ, Cork MJ et al. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol 2006; 67: 535-539.
37. Prescott NJ, Fisher SA, Onnie C, Pattni R, Steer S, Sanderson J et al. A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens 2005; 66: 318-320.
38. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-2777.
39. Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA. Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 2005; 52: 358-360.
40. Wesoly J, van der Helm-van Mil AH, Toes RE, Chokkalingam AP, Carlton VE, Begovich AB et al. Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum 2005; 52: 2948-2950.
41. Wesoly J, Hu X, Thabet MM, Chang M, Uh H, Allaart CF et al. The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population. Rheumatology (Oxford) 2007; 46: 617-621.
42. Zhernakova A, Eerligh P, Wijmenga C, Barrera P, Roep BO, Koeleman BP. Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun 2005; 6: 459-461.
43. Pazar B, Gergely Jr P, Nagy ZB, Gombos T, Pozsonyi E, Rajczy K et al. Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. Clin Exp Rheumatol 2008; 26: 1146-1152.
44. Ittah M, Gottenberg JE, Proust A, Hachulla E, Puechal X, Loiseau P et al. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome. Genes Immun 2005; 6: 457-458.
45. Vandiedonck C, Capdevielle C, Giraud M, Krumeich S, Jais JP, Eymard B et al. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 2006; 59: 404-407.
46. Balada E, Simeon-Aznar CP, Serrano-Acedo S, Martinez-Lostao L, Selva-O'Callaghan A, Fonollosa-Pla V et al. Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis. Clin Exp Rheumatol 2006; 24: 321-324.
47. Rueda B, Nunez C, Orozco G, Lopez-Nevot MA, de la Concha EG, Martin J et al. C1858T functional variant of PTPN22 gene is not associated with celiac disease genetic predisposition. Hum Immunol 2005; 66: 848-852.
48. Santin I, Castellanos-Rubio A, Aransay AM, Castano L, Vitoria JC, Bilbao JR. The functional R620W variant of the PTPN22 gene is associated with celiac disease. Tissue Antigens 2008; 71: 247-249.
49. Laberge GS, Birlea SA, Fain PR, Spritz RA. The PTPN22-1858C4T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Pigment Cell Melanoma Res 2008; 21: 206-208.
50. Latiano A, Palmieri O, Valvano MR, Bossa F, Latiano T, Corritore G et al. Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis 2007; 13: 1212-1219.
51. Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C et al. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 2008; 31: 534-538.
52. Saccucci P, Del DE, Rapini N, Verrotti A, Piccinini S, Maccari A et al. Association between PTPN22 C1858T and type 1 diabetes: a replication in continental Italy. Tissue Antigens 2008; 71: 234-237.
53. Saccucci P, Banci M, Cozzoli E, Neri A, Magrini A, Bottini E et al. Atherosclerosis and PTPN22: a study in coronary artery disease. Cardiology 2011; 119: 54-56.
54. Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G et al. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 2011; 20: 501-506.
55. Morgan AR, Han DY, Huebner C, Lam WJ, Fraser AG, Ferguson LR. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population. Tissue Antigens 2010; 76: 119-125.
56. Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res Ther 2006; 8: R27.
57. Chagastelles PC, Romitti M, Trein MR, Bandinelli E, Tschiedel B, Nardi NB. Association between the 1858T allele of the protein tyrosine phosphatase nonreceptor type 22 and type 1 diabetes in a Brazilian population. Tissue Antigens 2010; 76: 144-148.
58. De Jager PL, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A et al. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. Eur J Hum Genet 2006; 14: 317-321.
59. Gomes FM, Bianco B, Teles JS, Christofolini DM, de Souza AM, Guedes AD et al. PTPN22 C1858T polymorphism in women with endometriosis. Am J Reprod Immunol 2010; 63: 227-232.
60. Gomez LM, Anaya JM, Gonzalez CI, Pineda-Tamayo R, Otero W, Arango A et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 2005; 6: 628-631.
61. Gourh P, Tan FK, Assassi S, Ahn CW, McNearney TA, Fischbach M et al. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I-and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 2006; 54: 3945-3953.
62. Gourh P, Agarwal SK, Martin E, Divecha D, Rueda B, Bunting H et al. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 2010; 34: 155-162.
63. Reddy MV, Wang H, Liu S, Bode B, Reed JC, Steed RD et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun 2011; 12: 208-212.
64. Sachdev A, Bhanusali DG, Patterson KC, Zamora MB, Ghuman A, Gerlach JA et al. PTPN22 1858T is not a risk factor for North American pemphigus vulgaris. Exp Dermatol 2011; 20: 514-519.
65. Steck AK, Liu SY, McFann K, Barriga KJ, Babu SR, Eisenbarth GS et al. Association of the PTPN22/LYP gene with type 1 diabetes. Pediatr Diabetes 2006; 7: 274-278.
66. Thompson SD, Sudman M, Ramos PS, Marion MC, Ryan M, Tsoras M et al. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum 2010; 62: 3265-3276.
67. van OM, Wintle RF, Liu X, Yazdanpanah M, Gu X, Newman B et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005; 52: 1993-1998.
68. Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun 2006; 7: 693-695.
69. Alkhateeb A, Qarqaz F, Al-Sabah J, Al RT. Clinical characteristics and PTPN22 1858C/T variant analysis in Jordanian Arab vitiligo patients. Mol Diagn Ther 2010; 14: 179-184.
70. Anis SK, bdel Ghany EA, Mostafa NO, Ali AA. The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura. Blood Coagul Fibrinolysis 2011; 22: 521-525.
71. Ates A, Karaaslan Y, Karatayli E, Ertugrul E, Aksaray S, Turkyilmaz A et al. Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients. Tissue Antigens 2011; 78: 56-59.
72. Chabchoub G, Teixiera EP, Maalej A, Ben HM, Bahloul Z, Cornelis F et al. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol 2009; 36: 342-349.
73. Lamsyah H, Rueda B, Baassi L, Elaouad R, Bottini N, Sadki K et al. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens 2009; 74: 228-232.
74. Sahin N, Gunduz F, Inanc N, Direskeneli H, Saruhan-Direskeneli G. No association of PTPN22 gene polymorphism with rheumatoid arthritis in Turkey. Rheumatol Int 2009; 30: 81-83.
75. Sfar I, Ben AW, Mouelhi L, Aouadi H, Ben RT, Makhlouf M et al. Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World J Gastroenterol 2010; 16: 479-483.
76. Tikly M, Govind N, Frost J, Ramsay M. The PTPN22 R620W polymorphism is not associated with systemic rheumatic diseases in South Africans. Rheumatology (Oxford) 2010; 49: 820-821.
77. Ikari K, Momohara S, Inoue E, Tomatsu T, Hara M, Yamanaka H et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology (Oxford) 2006; 45: 1345-1348.
78. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 2006; 140: 586-593.
79. Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 2009; 60: 364-371.
80. Pemberton TJ, Mehta NU, Witonsky D, Di RA, Allayee H, Conti DV et al. Prevalence of common disease-associated variants in Asian Indians. BMC Genet 2008; 9: 13.
81. Zhang ZH, Chen F, Zhang XL, Jin Y, Bai J, Fu SB. PTPN22 allele polymorphisms in Chinese populations. Int J Immunogenet 2008; 35: 433-437.
82. Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009; 27: 363-391.
83. Laddha NC, Dwivedi M, Shajil EM, Prajapati H, Marfatia YS, Begum R. Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population. J Dermatol Sci 2008; 49: 260-262.
84. Sfar I, Dhaouadi T, Habibi I, Abdelmoula L, Makhlouf M, Ben RT et al. Functional polymorphisms of PTPN22 and FcgR genes in Tunisian patients with rheumatoid arthritis. Arch Inst Pasteur Tunis 2009; 86: 51-62.
85. Dultz G, Matheis N, Dittmar M, Rohrig B, Bender K, Kahaly GJ. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid 2009; 19: 143-148.
86. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Fichna P, Nowak J. PTPN22, PDCD1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Polish patients. Int J Immunogenet 2010; 37: 367-372.
87. Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K. Sexspecific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 2005; 153: 895-899.
88. Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T, Ilonen J. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in Berlin, Germany. Exp Clin Endocrinol Diabetes 2010; 118: 245-249.
89. Korolija M, Renar IP, Hadzija M, Medvidovic EP, Pavkovic P, Jokic M et al. Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians. Diabetes Res Clin Pract 2009; 86: e54-e57.
90. Maziarz M, Janer M, Roach JC, Hagopian W, Palmer JP, Deutsch K et al. The association between the PTPN22 1858C4T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun 2010; 11: 406-415.
91. Santiago JL, Martinez A, de la CH, Fernandez-Arquero M, Figueredo MA, de la Concha EG et al. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population. BMC Med Genet 2007; 8: 54.
92. Coenen MJ, Trynka G, Heskamp S, Franke B, van Diemen CC, Smolonska J et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009; 18: 4195-4203.
93. Dieude P, Teixeira VH, Pierlot C, Cornelis F, Petit-Teixeira E. Testing for linkage and association with rheumatoid arthritis a ptpn22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population. Ann Rheum Dis 2008; 67: 900-901.
94. Farago B, Talian GC, Komlosi K, Nagy G, Berki T, Gyetvai A et al. Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 2009; 29: 793-796.
95. Harrison P, Pointon JJ, Farrar C, Brown MA, Wordsworth BP. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2006; 45: 1009-1011.
96. Hinks A, Barton A, John S, Bruce I, Hawkins C, Griffiths CE et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005; 52: 1694-1699.
97. Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dosedependent manner but not with HLA-SE status. Genes Immun 2005; 6: 129-133.
98. Majorczyk E, Pawlik A, Kusnierczyk P. PTPN22 1858C4T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy. Int Immunopharmacol 2010; 10: 1626-1629.
99. Morgan AW, Robinson JI, Conaghan PG, Martin SG, Hensor EM, Morgan MD et al. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Res Ther 2010; 12: R57.
100. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J et al. Rheumatoid arthritis association with the FCRL3-169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006; 54: 3820-3827.
101. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW et al. Replication of putative candidate-gene associations with rheumatoid arthritis in 44,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005; 77: 1044-1060.
102. Simkins HM, Merriman ME, Highton J, Chapman PT, O'Donnell JL, Jones PB et al. Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. Arthritis Rheum 2005; 52: 2222-2225.
103. Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V et al. Association analysis of the 1858C4T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005; 6: 271-273.
104. Aksoy R, Duman T, Keskin O, Duzgun N. No association of PTPN22 R620 W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Mol Biol Rep 2011; 38: 5393-5396.
105. Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, Namjou B et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2533-2540.
106. Orozco G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, Caliz R et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219-224.
107. Piotrowski P, Lianeri M, Wudarski M, Lacki JK, Jagodzinski PP. Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. Clin Exp Rheumatol 2008; 26: 1099-1102.
108. Reddy MV, Johansson M, Sturfelt G, Jonsen A, Gunnarsson I, Svenungsson E et al. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1. Genes Immun 2005; 6: 658-662.
109. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004; 89: 5862-5865.
110. Roycroft M, Fichna M, McDonald D, Owen K, Zurawek M, Gryczynska M et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxford) 2009; 70: 358-362.
111. Carr EJ, Niederer HA, Williams J, Harper L, Watts RA, Lyons PA et al. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet 2009; 10: 121.
112. Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 2005; 52: 4039-4043.
113. Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E et al. Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 2010; 69: 1049-1053.
114. Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010; 362: 1686-1697.
115. Chuang WY, Strobel P, Belharazem D, Rieckmann P, Toyka KV, Nix W et al. The PTPN22 gain-of-function\+1858T(\+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis. Genes Immun 2009; 10: 667-672.
116. Greve B, Hoffmann P, Illes Z, Rozsa C, Berger K, Weissert R et al. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with antititin antibody-positive myasthenia gravis. Hum Immunol 2009; 70: 540-542.
117. Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, Fisher SA et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009; 136: 523-529.
118. az-Gallo LM, Gourh P, Broen J, Simeon C, Fonollosa V, Ortego-Centeno N et al. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis 2011; 70: 454-462.
119. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010; 42: 426-429.
120. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
121. Matesanz F, Rueda B, Orozco G, Fernandez O, Leyva L, Alcina A et al. Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol 2005; 252: 994-995.
122. Huffmeier U, Reis A, Steffens M, Lascorz J, Bohm B, Lohmann J et al. Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol 2006; 126: 932-935.
123. Smith RL, Warren RB, Eyre S, Ke X, Young HS, Allen M et al. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol 2008; 158: 962-968.
124. Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE et al. Genomewide association analysis identifies three psoriasis susceptibility loci. Nat Genet 2010; 42: 1000-1004.
125. Juneblad K, Johansson M, Rantapaa-Dahlqvist S, Alenius GM. Association between the PTPN22 \+1858 C/T polymorphism and psoriatic arthritis. Arthritis Res Ther 2011; 13: R45.
126. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-117.
127. Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum 2008; 58: 3247-3254.
128. D'Silva KJ, Zamora MB, Gerlach J, Schwartz KA. Increased representation of the PTPN22 mutation in patients with immune thrombocytopenia. J Thromb Haemost 2010; 8: 2076-2078.
129. Martin TM, Bye L, Modi N, Stanford MR, Vaughan R, Smith JR et al. Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Mol Vis 2009; 15: 208-212.
130. Milkiewicz P, Pache I, Buwaneswaran H, Liu X, Coltescu C, Heathcote EJ et al. The PTPN22 1858T variant is not associated with primary biliary cirrhosis. Tissue Antigens 2006; 67: 434-437.
131. Orozco G, Garcia-Porrua C, Lopez-Nevot MA, Raya E, Gonzalez-Gay MA, Martin J. Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity. Ann Rheum Dis 2006; 65: 687-688.
132. Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123-127.
133. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
134. Charatcharoenwitthaya P, Lindor KD. Primary sclerosing cholangitis: diagnosis and management. Curr Gastroenterol Rep 2006; 8: 75-82.
135. Amagai M. Pemphigus vulgaris and its active disease mouse model. Curr Dir Autoimmun 2008; 10: 167-181.
136. Mejri K, Kallel-Sellami M, Petit-Teixeira E, Abida O, Mbarek H, Zitouni M et al. PTPN22 R620W polymorphism is not associated with pemphigus. Br J Dermatol 2007; 157: 1068-1069.
137. Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007; 40: 453-461.
138. Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G, Massad C et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 2011; 121: 3635-3644.
139. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 2011; 43: 902-907.
140. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
141. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
142. Anderson AC, Nicholson LB, Legge KL, Turchin V, Zaghouani H, Kuchroo VK. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J Exp Med 2000; 191: 761-770.
143. Bruno R, Sabater L, Sospedra M, Ferrer-Francesch X, Escudero D, Martinez-Caceres E et al. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur J Immunol 2002; 32: 2737-2747.
144. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.